Stay updated on PF-07038124 Safety & PK in Healthy Participants Clinical Trial
Sign up to get notified when there's something new on the PF-07038124 Safety & PK in Healthy Participants Clinical Trial page.

Latest updates to the PF-07038124 Safety & PK in Healthy Participants Clinical Trial page
- Check7 days agoChange DetectedThe page displays the ClinicalTrials.gov record for Pfizer’s completed Phase 1 study of topical PF-07038124, including its study design, eligibility criteria, outcomes, and record history.SummaryDifference53%

- Check14 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check21 days agoChange DetectedA sitewide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe displayed site revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check56 days agoChange DetectedThe study page now displays a 403 Forbidden error indicating restricted access to the record. The visible content is replaced by a minimal site header/footer and an error message rather than the study details.SummaryDifference19%

Stay in the know with updates to PF-07038124 Safety & PK in Healthy Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07038124 Safety & PK in Healthy Participants Clinical Trial page.